These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 1720286)

  • 1. Study of the effects of paf-acether on human nasal airways.
    Leggieri E; Tedeschi A; Lorini M; Bianco A; Miadonna A
    Allergy; 1991 Aug; 46(6):466-71. PubMed ID: 1720286
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence of PAF-acether metabolic pathway activation in antigen challenge of upper respiratory airways.
    Miadonna A; Tedeschi A; Arnoux B; Sala A; Zanussi C; Benveniste J
    Am Rev Respir Dis; 1989 Jul; 140(1):142-7. PubMed ID: 2546468
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nasal eosinophilia induced by PAF-acether is accompanied by the release of eosinophil cationic protein.
    Tedeschi A; Milazzo N; Miadonna A
    Eur Respir J; 1994 Aug; 7(8):1445-51. PubMed ID: 7525344
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nasal neutrophilia and eosinophilia induced by challenge with platelet activating factor.
    Tedeschi A; Palumbo G; Milazzo N; Miadonna A
    J Allergy Clin Immunol; 1994 Feb; 93(2):526-33. PubMed ID: 8120279
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platelet-activating factor nasal challenge induces nasal congestion and reduces nasal volume in both healthy volunteers and allergic rhinitis patients.
    Muñoz-Cano R; Valero A; Roca-Ferrer J; Bartra J; Sanchez-Lopez J; Mullol J; Picado C
    Am J Rhinol Allergy; 2013; 27(2):e48-52. PubMed ID: 23562190
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nasal allergen challenge generates 1-0-hexadecyl-2-lyso-sn-glycero-3-phosphocholine.
    Shin MH; Averill FJ; Hubbard WC; Chilton FH; Baroody FM; Liu MC; Naclerio RM
    Am J Respir Crit Care Med; 1994 Mar; 149(3 Pt 1):660-6. PubMed ID: 8118633
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of platelet-activating factor (PAF) on nasal airway resistance in healthy subjects is not mediated by nitric oxide.
    Maniscalco M; Sofia M; Faraone S; Carratù L
    Allergy; 2000 Aug; 55(8):757-61. PubMed ID: 10955702
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Local cellular and humoral responses to antigenic and distilled water challenge in subjects with allergic rhinitis.
    Meslier N; Braunstein G; Lacronique J; Dessanges JF; Rakotosihanaka F; Devillier P; Lockhart A; Mencia-Huerta JM; Boushey HA
    Am Rev Respir Dis; 1988 Mar; 137(3):617-24. PubMed ID: 3345042
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of platelet-activating factor on the responsiveness of the human nasal airway.
    Austin CE; Foreman JC
    Br J Pharmacol; 1993 Sep; 110(1):113-8. PubMed ID: 8220870
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of histamine-induced nasal obstruction by cetirizine in allergic rhinitis.
    Braunstein G; Malaquin F; Fajac I; Melac M; Frossard N
    Br J Clin Pharmacol; 1992 Apr; 33(4):445-8. PubMed ID: 1349494
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nasal neutrophilia and release of myeloperoxidase induced by nasal challenge with platelet activating factor: different degrees of responsiveness in atopic and nonatopic subjects.
    Miadonna A; Milazzo N; Lorini M; Sala A; Tedeschi A
    J Allergy Clin Immunol; 1996 Apr; 97(4):947-54. PubMed ID: 8655890
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nasal response of rhinitic and non-rhinitic subjects to histamine and methacholine: a comparative study.
    Corrado OJ; Gould CA; Kassab JY; Davies RJ
    Thorax; 1986 Nov; 41(11):863-8. PubMed ID: 3547756
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nasal challenge with serotonin in asymptomatic hay fever patients.
    Tønnesen P; Schaffalitzky de Muckadell OB; Mygind N
    Allergy; 1987 Aug; 42(6):447-50. PubMed ID: 2444128
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effects of anti-PAF agents on nasal response after allergen challenge in guinea pigs].
    Narita S; Asakura K; Shirasaki H; Kojima T; Saitoh H; Kataura A
    Nihon Jibiinkoka Gakkai Kaiho; 1992 Aug; 95(8):1190-7. PubMed ID: 1357119
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of platelet activating factor on the human nasal mucosa.
    Pipkorn U; Karlsson G; Bake B
    Allergy; 1984 Feb; 39(2):141-5. PubMed ID: 6703263
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Detection of platelet-activating factor in nasal lavage fluid from patients with pollinosis and experimental animals with nasal allergy].
    Shirasaki H; Asakura K
    Nihon Jibiinkoka Gakkai Kaiho; 1990 Mar; 93(3):420-7. PubMed ID: 2352050
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of threshold criteria for the nasal histamine challenge test in perennial allergic rhinitis.
    Kanthawatana S; Maturim W; Fooanant S; Manorot M; Trakultivakorn M
    Asian Pac J Allergy Immunol; 1997 Jun; 15(2):65-9. PubMed ID: 9346268
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thresholds in nasal histamine challenge in patients with allergic rhinitis, patients with hyperreflectory rhinopathy, and healthy volunteers.
    Wuestenberg EG; Hauswald B; Huettenbrink KB
    Am J Rhinol; 2004; 18(6):371-5. PubMed ID: 15706984
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Excretion of platelet activating factor-acetylhydrolase and phospholipase A2 into nasal fluids after allergenic challenge: possible role in the regulation of platelet activating factor release.
    Touqui L; Herpin-Richard N; Gene RM; Jullian E; Aljabi D; Hamberger C; Vargaftig BB; Dessange JF
    J Allergy Clin Immunol; 1994 Jul; 94(1):109-19. PubMed ID: 8027488
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nasal reactions elicited by unilateral allergen challenge.
    Malmberg H; Binder E; Fräki J; Harvima I; Salo O; Holopainen E
    Acta Otolaryngol; 1989; 107(5-6):446-9. PubMed ID: 2474232
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.